Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G

Journal of Pediatrics

Volumn 130, Issue 2, 1997, Pages 281-283

  Kattamis, A C ^a   Shankar, S ^a   Cohen, A R ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADOLESCENT; ARTICLE; ASEPTIC MENINGITIS; CHILD; CHILDHOOD DISEASE; HEADACHE; HEALTH CARE COST; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORBIDITY; NAUSEA; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL;

EID: 0030722514     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70355-X     Document Type: Article

References (5)

1. DS. Beardsley Platelet abnormalities in infancy and childhood 4th ed DG Nathan FA Oski Hematology of infancy and childhood. 1993 WB Saunders Philadelphia 1561 1604
2. VS Blanchette B Luke M Andrew A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura J Pediatr 123 1993 989 995
3. C Duhem MA Dicato F. Ries Side-effects of intravenous immune globulins Clin Exp Immunol 1 1994 79 83
4. CL Scribner RM Kapit ET Phillips NM. Rickles Aseptic meningitis and intravenous immunoglobulin therapy Ann Intern Med 121 1994 305 306
5. EA Sekul EJ Cupler MC. Dalakas Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors Ann Intern Med 121 1994 259 262